The Wesley Center for Immunotherapy at UH Seidman Cancer Center

At the Wesley Center for Immunotherapy, UH experts are creating cells for CAR T-cell treatment in a rapid one-day manufacturing protocol that can be administered a few days later. This is an improvement over the previous eight-day manufacturing process and vastly different from getting CAR T-cells from a commercial vendor, which can take three to four weeks for a patient’s specifically modified cells to even arrive. This innovation allows UH Seidman Cancer Center physicians to deliver therapy in a timely manner and to more patients than would otherwise be possible. In fact, researchers at UH are developing a CAR-T cell therapy line that will require only standard phlebotomy T-cell collection to produce CAR-T cells, making it possible in the near future to offer CAR T-cell therapy in other locations.